Adam Frederik Sander Bertelsen

Adam Frederik Sander Bertelsen

Professor

ORCID: 0000-0002-8782-7830

Publication year:
All
1 - 8 out of 8Page size: 10
  1. 2022
  2. Published

    A capsid virus-like particle-based SARS-CoV-2 vaccine induces high levels of antibodies and protects Rhesus macaques

    Volkmann, A., Koopman, G., Mooij, P., Verschoor, E. J., Verstrepen, B. E., Bogers, W. M. J. M., Idorn, M., Paludan, S. R., Vang, S., Nielsen, Morten Agertoug, Sander, Adam F. , Schmittwolf, C., Hochrein, H. & Chaplin, P., 2022, In: Frontiers in Immunology. 13, p. 857440

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice

    van Oosten, L., Yan, K., Rawle, D. J., Le, T. T., Altenburg, J. J., Fougeroux, Cyrielle Elyette, Goksøyr, L., de Jongh, W. A., Nielsen, Morten Agertoug, Sander, Adam F. , Pijlman, G. P. & Suhrbier, A., 2022, In: Journal of Virology. 96, 14, 00844-22.

    Research output: Contribution to journal › Letter › Research › peer-review

  4. Published

    Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein

    Ximba, P., Chapman, R., Meyers, A., Margolin, E., van Diepen, M. T., Sander, Adam F. , Woodward, J., Moore, P. L., Williamson, A. L. & Rybicki, E. P., 2022, In: Nanotechnology. 33, 48, 16 p., 485102.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature

    Aves, Kara-Lee, Janitzek, C. M., Fougeroux, Cyrielle Elyette, Theander, Thor Grundtvig & Sander, Adam F. , 2022, In: Pharmaceutics. 14, 6, 1301.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis

    Goksøyr, L., Funch, Anders Boutrup, Okholm, A. K., Theander, Thor Grundtvig, de Jongh, W. A., Bonefeld, Charlotte Menne & Sander, Adam F. , 2022, In: Vaccines. 10, 5, 828.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    The C-terminal tail of α-synuclein protects against aggregate replication but is critical for oligomerization

    Farzadfard, A., Pedersen, J. N., Meisl, G., Somavarapu, A. K., Alam, P., Goksøyr, L., Nielsen, Morten Agertoug, Sander, Adam F. , Knowles, T. P. J., Pedersen, J. S. & Otzen, D. E., 2022, In: Communications Biology . 5, 1, 123.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers

    Prentø, Jannick, Janitzek, C. M., Velázquez-Moctezuma, R., Sørensen, Andreas Holst Holmegaard, Jørgensen, T., Clemmensen, S., Soroka, V., Thrane, Susan, Theander, Thor Grundtvig, Nielsen, Morten Agertoug, Salanti, Ali, Bukh, Jens & Sander, Adam F. , 2022, In: npj Vaccines. 7, 148.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Virus-like particles displaying recombinant Der p 1 allergen to optimize IgG blocking antibody response

    Jitthamstaporn, S., Sander, Adam F. & Jacquet, A., 2022, In: Allergy: European Journal of Allergy and Clinical Immunology. 77, 2, p. 664-667

    Research output: Contribution to journal › Letter › Research › peer-review

ID: 365538742